Mai Capital Management Regeneron Pharmaceuticals, Inc. Transaction History
Mai Capital Management
- $10.1 Billion
- Q3 2024
A detailed history of Mai Capital Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mai Capital Management holds 3,781 shares of REGN stock, worth $2.56 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,781
Previous 4,031
6.2%
Holding current value
$2.56 Million
Previous $4.24 Million
6.19%
% of portfolio
0.04%
Previous 0.04%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
82.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.71 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.06 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.31 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.9 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...